Abstract
A prospective, multi-center, observational study on the use of interferon beta-1a (Rebif) therapy in Egyptian patients with Multiple Sclerosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
